Skip to main content
PMC home page
BMC Cardiovascular Disorders logoLink to BMC Cardiovascular Disorders
. 2020 May 19;20:231. doi: 10.1186/s12872-020-01508-y

A cardiovascular disease risk factor in children with congenital heart disease: unmasking elevated waist circumference - a CHAMPS* study *CHAMPS: Children’s Healthy-Heart Activity Monitoring Program in Saskatchewan

Erin Barbour-Tuck 1, Natasha G Boyes 2, Corey R Tomczak 2, Dana S Lahti 2, Chantelle L Baril 2, Charissa Pockett 1, Shonah Runalls 2, Ashok Kakadekar 1, Scott Pharis 1, Timothy J Bradley 1, Kristi D Wright 3, Marta C Erlandson 2,✉
PMCID: PMC7236104  PMID: 32429858

Abstract

Background

Children with congenital heart disease (CHD) have an elevated risk of future cardiovascular disease but the underlying mechanisms are unclear. Abdominal obesity (measured as waist circumference) is a risk factor for adult onset of cardiovascular diseases and is correlated with low physical activity levels, commonly found in children with congenital heart disease. Elevated waist circumference may be a mechanism by which cardiovascular disease risk is elevated in children with CHD. The purpose of this study was to compare waist circumference between children with and without CHD, while considering potential confounders. We hypothesized that children with CHD would have higher measures of waist circumference when controlling for differences in birthweight, lean mass, and physical activity.

Methods

Thirty-two children with CHD (10.9 ± 2.6 years; 12 female) from the Children’s Healthy-Heart Activity Monitoring Program in Saskatchewan, and 23 healthy controls (11.7 ± 2.5 years; 10 female) were studied. Waist circumference, physical activity (physical activity questionnaire), body composition (lean mass; dual x-ray absorptiometry), and birthweight were assessed. Analysis of covariance, Mann-Whitney U, and independent sample t-tests were used to assess group differences (p < 0.05).

Results

Children with CHD had greater waist circumference than controls, controlling for lean mass, physical activity, birthweight, and sex (F (1, 49) = 4.488, p = 0.039). Physical activity, lean mass, and birthweight were not significantly different between groups (p > 0.05).

Conclusion

Our findings generate a novel hypothesis—higher waist circumferences in children with CHD compared to age-matched controls, may contribute to an elevated risk of cardiovascular disease.

Keywords: Congenital heart disease, Abdominal obesity, Physical activity, Cardiometabolic risk, Waist circumference

Background

Adults with congenital heart disease (CHD) may have a greater risk than their healthy peers for developing cardiovascular and metabolic diseases such as type II diabetes and atherosclerosis [1–4]. Preclinical markers and risk factors of these diseases (e.g., hypertension, dyslipidemia, dysglycemia, arterial stiffness, and low exercise capacity) arise during childhood in association with elevated adiposity and waist circumference, and low physical activity [5–10]. The prevalence of low physical activity, overweight, and obesity in children with CHD [11–15] may account for disparities in preclinical markers in childhood and cardiovascular and metabolic diseases in this population later in life [16]. The relationships between physical activity, body fat, and body mass index (BMI) with health are ubiquitous; however, they do not entirely explain the observed differences in preclinical markers or fitness between children with CHD and healthy peers. Identifying other contributing factors to cardiovascular and metabolic risk is important for preventing adult disease in individuals with CHD.

Elevated waist circumference, a surrogate measure of abdominal fat deposition, may be a contributing factor in the process linking CHD to adult cardiovascular disease. Abdominal fat is highly metabolically active and produces elevated levels of circulating blood lipids [17] and inflammatory cytokines such as tumor necrosis factor-α and interleukins [18]. In healthy populations, waist circumference has been linked to low birthweight, catch-up growth, and low physical activity; further, there are longitudinal relationships between birthweight, early childhood growth, and childhood abdominal fat and adult cardiovascular health [7, 9, 10, 19–21]. Children with CHD are susceptible to low birthweight, catch-up growth, and low physical activity [22–24]. Therefore, elevated waist circumference during childhood may pose a similar cardiovascular disease risk to children with CHD as it does in other populations, but to date this has not been properly explored.

Studies in children with CHD often measure only body fat or identify overweight by BMI, and conclude that there are no differences in fatness between CHD and healthy children contributing to the differences in health markers (i.e., arterial stiffness, fitness, etc.) [14, 16], but these observations may be incomplete. Waist circumference is often overlooked in the analyses [25], or the analyses do not account for key potential moderators of waist circumference such as birthweight, sex, body size, and physical activity [16, 26]. The inclusion of waist circumference and its moderators may be critical to understanding the mechanisms behind the high rates of cardiometabolic diseases in this population. Therefore, the purpose of this study was to examine waist circumference between children with and without CHD, while considering potential confounders. We hypothesized that children with CHD would have higher measures of waist circumference compared to healthy age-matched controls.

Methods

Study participants included 32 children (12 female) with CHD with an age range of 7–16 years (10.9 ± 2.6 years) from the Children’s Healthy-Heart Activity Monitoring Program in Saskatchewan (CHAMPS), and 23 (10 females) age- and sex-matched healthy controls, with an age range of 7–16 years (11.7 ± 2.5 years). CHD conditions included Fontan circulation [n = 7; pre-Fontan circulation CHD included hypoplastic left heart syndrome (n = 4), hypoplastic right heart syndrome (n = 1), right ventricular single ventricle with transposition of the great arteries and pulmonary stenosis (n = 1), and tricuspid atresia with multiple ventricular septal defects (n = 1)], tetralogy of Fallot (n = 5), heart transplantation [n = 4; underlying heart lesion of dilated cardiomyopathy (n = 2), hypoplastic left heart syndrome (n = 1), and tricuspid atresia with pulmonary stenosis (n = 1)], transposition of the great arteries (n = 3), septal defects (n = 3; 1 atrial and 2 ventricular), coarctation of the aorta (n = 2), cardiomyopathy (n = 2), double outlet right ventricle (n = 2), pulmonary stenosis (n = 2), aortic stenosis (n = 1), and tricuspid atresia (n = 1). Of the children with CHD, 31 were post-operative (mean time post-operative 7.3 ± 4.1 years) and 1 had not undergone surgical repair or device implantation. CHD diagnoses and surgical details are further described in Table 1. Children in our sample were ethnically similar, with 87% of those with CHD and 100% of controls self-identifying as European-white. Four children (13%) identified as other than European-white: one as Caucasian/Filipino, one as Métis, one as Chinese, one as Caucasian/Latino (Spanish). The study population included all children from the larger CHAMPS cohort (n = 38) with complete waist circumference, physical activity and body composition data. Ethical approval was obtained from the University of Saskatchewan’s Biomedical Research Ethics Board and written parental consent and child assent were obtained prior to testing.

Table 1.

Diagnostic and surgical features of children with CHD

CHD # Age at Study (years) Age at Surgery Time since Surgery (years) Weight at Study (kg) Weight at Surgery (kg) NYHA Class Diagnosis Surgical Procedure Medications
1 9 11 days 9 31.5 Unknown I Pulmonary stenosis Balloon valvuloplasty –
2 10 N/A N/A 34.5 N/A I Idiopathic dilated cardiomyopathy None ASA, Carvedilol, Enalapril, Spironolactone
3 14

aNeonate;

b9 years;

c13 years

 1 48.0 Unknown I Aortic stenosis

aBalloon valvuloplasty;

b-cAortic valve reconstruction × 2

 ASA, Ranitidine, Warfarin
4 10

a1 day;

b10 days;

c2 years;

d4 years

 6 33.0 d15.8 I Transposition of the great arteries

aBalloon atrial septostomy;

bArterial switch;

cBalloon branch pulmonary artery stenosis;

dRight ventricular outflow tract patch

 –
5 12 3 months 12 48.0 4.5 I Tetralogy of Fallot Tetralogy of Fallot repair Fluoxetine, Lisdexamfetamine, Melatonin
6 14

a8 days;

b10 months;

c3 years;

d6 years

 8 38.7 d18.8 I Hypoplastic left heart syndrome

aNorwood/BT shunt;

bGlenn;

cFontan;

dTricuspid valve reconstruction

 ASA, Enalapril
7 9 6 months 8.5 28.0 7.6 I Double outlet right ventricle, atrial septal defect Atrial and ventricular septal defect patches, right ventricular muscle bundle resection, main pulmonary artery arterioplasty –
8 9 6 months 8.5 35.0 7.2 I Tetralogy of Fallot Ventricular septal defect patch, right ventricle muscle bundle resection, pulmonary valvuloplasty ASA
9 13

a2 weeks;

b6 months;

c2.75 years

 10 57.0 Unknown I Hypoplastic left heart syndrome

aNorwood/BT shunt;

bGlenn;

cFontan

 ASA
10 8 18 months 6.5 27.0 12.0 I Idiopathic dilated cardiomyopathy Heart transplant

Atorvastatin, Cyclosporine,

Enalapril, Mycophenolic acid, Vitamin D
11 14

a3 months;

b2 years

 12 44.0 Unknown I Tricuspid atresia, ventricular septal defect

aGlenn;

bFontan

 ASA, Norethisterone
12 9

a1 month;

b5 month

 8.5 27.0 Unknown I Coarctation of the aorta

aEnd-to-end coarctation repair;

bBalloon recoarctation

 –
13 16 12 years 4 135.0 83.0 I Dilated/restrictive cardiomyopathy Transplant Atorvastatin, Mycophenolic acid, Tacrolimus, Vitamin D
14 9 a7 months; b5 years 4 47.5 18.6 I Pulmonary stenosis, atrial septal defect, tricuspid regurgitation

aBalloon valvuloplasty;

bAtrial septal defect closure and tricuspid valve repair

 Fluticasone propionate, Salbutamol, Omega 3
15 8 7 years 1 21.8 Unknown I Congenitally corrected transposition of the great arteries Pacemaker ASA, Methylphenidate
16 13 10 years 3 35.5 32.0 I Perimembraneous ventricular septal defect Perimembraneous ventricular septal defect suture closure, right ventricular muscle bundle resection –
17 10

a10 days;

b1 year;

c1 year

 9 27.0 Unknown IV Tricuspid atresia, pulmonary stenosis

aRight BT shunt;

bLeft BT shunt;

cGlenn;

 ASA, Enalapril, Omeprazole
18 11

a2 weeks;

b5 months

 10.5 33.0

a2.6;

b5.6

 I Tetralogy of Fallot

aRight BT shunt;

bTetralogy of Fallot repair

 –
19 10

a8 days;

b6 months;

c2.5 years

 7 29.0

a3.2;

b7.1;

c14 .0

 I Hypoplastic left heart syndrome

aNorwood/Sano shunt;

bGlenn;

cFontan

 ASA, Enalapril
20 14

a2 weeks;

b1 year

 13 46.0 Unknown I Coarctation of the aorta, ventricular septal defect

aSubclavian flap coarctation repair;

bVentricular septal defect patch

 –
21 10 2 months 10 21.0 Unknown I Tetralogy of Fallot Tetralogy of Fallot repair ASA
22 13 5 months 13 50.0 Unknown I Tetralogy of Fallot Tetralogy of Fallot repair and pacemaker –
23 13

a3 days;

b5 months;

c2 years

 11 58.5 a3.8 I Right atrial isomerism, right ventricular single ventricle, transposition of the great arteries, pulmonary stenosis

aLeft BT shunt;

bGlenn;

cFontan

 ASA, Penicillin, Sotalol
24 14

a3 months;

b1 year

 13 52.0 Unknown I Left atrial isomerism, double outlet right ventricle, pulmonary stenosis, right-sided aortic arch

aLeft BT shunt;

bFull repair

 –
25 12

a2 weeks;

b9 months;

c2.75 years

 9 46.5 Unknown I Double outlet right ventricle, mitral atresia, hypoplastic left ventricle, interrupted aortic arch

aAortic arch repair and pulmonary artery band;

bGlenn;

cFontan

 ASA
26 14 12 years 2 81.0 64.0 I Hypertrophic cardiomyopathy Implantable Cardioverter Defibrillator Atenolol, Escitalopram, Medroxyprogesterone acetate Topiramate
27 8 4 years 4 27.5 17.4 I Sinus venosus atrial septal defect Atrial septal defect repair with Warden procedure ASA
28 7 5 years 2 28.0 19.0 I Ventricular septal defect, heart block Ventricular septal defect patch and pacemaker –
29 13 3 months 13 48.5 Unknown I Transposition greater arteries, atrial and ventricular septal defects Arterial switch, coarctation repair, atrial septal defect suture, ventricular septal defect patch –
30 7

a6 days;

b6 months;

c2 years;

d4 years

 3 30.0

a4.1;

b7.6;

c14.1;

d19.2

 I Dextrocardia, double inlet left ventricle, hypoplastic right ventricle, transposition of the great arteries, pulmonary atresia, ventricular septal defect

aRight BT shunt;

bGlenn;

cFontan;

dPacemaker

 ASA, Amantadine, Risperidone, Sertraline
31 7

a2 months;

b9 months;

c11 months;

d2 years;

e4.5 years

 2.5 28.0 d12.9; e18.0 I Tricuspid atresia, normally related great arteries, pulmonary stenosis

aRight BT shunt;

bLeft BT shunt;

cGlenn;

dFontan;

eTransplant

 Calcium, Fluticasone propionate, Methylphenidate, Mycophenolic Acid, Sertraline, Tacrolimus, Vitamins B2 and D
32 8

a10 days;

b5 months;

c4.5 years;

d7 years

 1 22.5

c13.1;

d19.1

 I Hypoplastic left heart syndrome

aNorwood/Sano shunt;

bGlenn;

cFontan; dTransplant

 Mycophenolic Acid, Tacrolimus, Vitamin D
Open in a new tab

CHD patient diagnosis, surgical procedure details, and medications at time of study. Multiple surgeries are lettered (a, b, c, etc.) and reported in the order of earliest to latest. ASA Acetylsalicylic acid, CHD Congenital heart disease, NYHA New York Heart Association

Anthropometrics

Waist circumference was measured as the midway point between the lowest rib and the iliac crest, generally corresponding to the smallest circumference, and recorded to the nearest 0.1 cm [27]. Height and sitting height were measured on a wall mounted stadiometer (Holtain Ltd., Crosswell, UK) and recorded to the nearest 0.1 cm. Weight was taken on a calibrated digital scale (Toledo Scale Company of Canada, Windsor, ON) and recorded to the nearest 0.1 kg. Birthweight was obtained by parental report.

Physical activity

Physical activity was assessed using the self-report 7-day recall Physical Activity Questionnaires for Children (7–13 years) or Adolescents (14–18 years) [28–30]. The Physical Activity Questionnaires for Children and Adolescents have demonstrated internal consistency and validity via moderate relationships with other 7-day activity recalls, teacher evaluations, and other measures of physical activity, including accelerometry [28–30]. The Physical Activity Questionnaires for Children and Adolescents use a 5-point Likert scale to yield a composite physical activity score, with a higher number indicating a greater level of physical activity. Participants were asked to recall their activities before school, during recess (elementary school only), lunch, after school, and after supper, and to select their general patterns of activity (i.e., sat and talked with friends versus ran around and played most of the time) for the last week. A researcher provided participants with verbal instruction on how to complete the questionnaire and remained available to answer questions. Participants, in accordance with the author-recommended questionnaire protocol, completed questionnaires with minimal input from parents.

Dual-energy x-ray absorptiometry (DXA)

DXA was used to assess body composition. A total body scan was taken in array mode by a certified technologist (QDR Discovery Wi; Hologic, Inc., Bedford, MD, USA) and scans were analyzed using QDR software for Windows XP (QDR Discovery, Hologic, Inc.) to assess total lean mass (g) and total fat mass (g), which were then used to calculate total % lean mass and total % fat mass.

Waist circumference covariates

Factors modulating waist circumference (sex, birthweight, physical activity, and total lean mass) were included as covariates in our statistical model based on previous studies and relationships identified in other populations [20, 31–34]. Sex was included in the model because the overall sample was unbalanced with more males than females, despite sex-matching between groups. Birthweight was included because of the known relationship between low birthweight and cardiovascular risk factors including abdominal fat in children [20, 35]. Physical activity was included because of known relationships to abdominal fat and cardiovascular risk factors in children [9]. Lean mass was included in the model to control for body size independent of fat mass and to eliminate the assumption of BMI regarding identical fractional body compositions (i.e., at a given BMI, not all individuals will have the same amount of fat mass) [34]. While DXA measures offer a more valid measure of abdominal fat, the selection of waist circumference as our dependent variable was deliberate as it is a more feasible, accessible, and non-invasive technique allowing for widespread use in pediatric clinics at no cost. Age was not used as a covariate given the control group was age-matched.

Statistical analysis

Dependent variables were assessed for normality using the Shapiro-Wilk test. Group differences in descriptive characteristics, including overweight and obesity prevalence (based on pediatric BMI cutoffs [36]), were assessed using independent sample t-tests for parametric variables and Mann-Whitney U for non-parametric variables. Data are reported as means ± standard deviation. The relationship between waist circumference and each covariate in both CHD and control groups were assessed using Pearson bivariate correlations. Physical activity score and waist circumference were divided into quartiles and the group relationships to quartiles were assessed using Pearson Chi-square analyses. Finally, the difference in waist circumference between the CHD and control groups was assessed using an analysis of covariance with sex, birthweight, physical activity, and lean mass as covariates. All analyses were assessed using SPSS version 24.0 (Chicago, IL, USA) and significance was accepted when p < 0.05.

Results

Child/adolescent descriptive characteristics by group are listed in Table 2. CHD and control groups were similar in age, birthweight, height, weight, BMI, total fat mass, total lean mass, percent fat mass, percent lean mass, and physical activity score (p > 0.05). Unadjusted waist circumference as indicated by the Mann-Whitney U test was not significantly different between CHD (mean rank = 28.5, sum of ranks = 913.0) and control groups (mean rank = 27.3, sum of ranks = 627.0; U = 351.0, p = 0.772).

Table 2.

Child/adolescent descriptive characteristics by study group

Control CHD p-value
N 23 32 –
Sex (M, F) 13, 10 20, 12 0.655a
Age (years) 11.7 ± 2.5 10.9 ± 2.6 0.268b
Birthweight (kg) 3.67 ± 0.58 3.38 ± 0.59 0.071
Height (m) 1.49 ± 0.17 1.44 ± 0.17 0.250
Weight (kg) 42.3 ± 15.3 41.3 ± 21.6 0.473b
BMI (kg/m2) 18.3 ± 3.1 18.9 ± 4.7 0.720b
Total fat mass (kg) 8.7 ± 5.1 10.4 ± 9.4 0.746b
Total lean mass (kg) 31.5 ± 10.5 29.1 ± 11.9 0.298b
Percent fat mass (%) 19.9 ± 5.3 22.8 ± 7.6 0.131b
Percent lean mass (%) 75.4 ± 5.4 73.1 ± 7.4 0.204
Physical activity score (1–5 scale) 3.35 ± 0.69 3.05 ± 0.71 0.117
Overweight/Obese prevalence 8% 17% 0.374
Open in a new tab

Data presented as means ± standard deviation. BMI Body mass index, CHD Congenital heart disease. Control, age- and sex-matched control group. aChi-square analysis; bMann-Whitney U analysis. No significant differences between groups

There were significant relationships between waist circumference and physical activity score in CHD (r = − 0.356, p = 0.045) and controls (r = − 0.691, p < 0.001); waist circumference and lean mass in CHD (r = 0.853, p < 0.001) and controls (r = 0.847, p < 0.001); and waist circumference and birthweight in CHD (r = 0.355, p = 0.046) but not controls (p = 0.057). There was no significant relationship between waist circumference and sex in either group (both p > 0.05).

There was no significant association between physical activity quartile and CHD/control group (x2 (3) = 5.036, p = 0.169) or between waist circumference quartile and CHD/control group (x2 (3) = 0.990, p = 0.804); however, there was a 26 cm difference in waist circumference identified between the top (56.8 ± 3.1 cm) and bottom quartile (83.2 ± 13.9 cm) of physical activity when groups were combined (p < 0.001).

The analysis of covariance revealed that CHD participants had a significantly greater waist circumference than controls (estimated marginal mean difference = 3.9 cm, 69.1 ± 6.6 cm vs. 65.1 ± 6.5, respectively) when controlling for sex, birthweight, physical activity score, and total lean mass (F (1, 49) = 4.488, p = 0.039; Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

Adjusted mean and standard deviation of waist circumference in children/adolescents with CHD (congenital heart disease; n = 32) and controls (n = 23). Group differences assessed by ANCOVA with sex, birthweight, physical activity, and lean mass as co-variates. *Indicates p = 0.039

Discussion

The major novel finding of this study was that waist circumference was greater in children with diverse CHD lesions in comparison to healthy peers, independent of sex, birthweight, total lean mass, and physical activity. In addition, higher physical activity levels are related to lower waist circumference in children with CHD; however, the analysis of covariance finding indicates that high physical activity in children with CHD may not equalize waist circumference to that of healthy controls. While our smaller sample size warrants validation of findings in a larger cohort, the hypothesis generated from this study is potentially of great clinical importance. Elevated waist circumference and abdominal fat may drive or be one of the contributing mechanisms of cardiovascular and metabolic disease risk in this population.

Importance of waist circumference determination in children with CHD

Studies have demonstrated that adipose tissue, particularly abdominal fat and specifically visceral fat, functions as an endocrine organ. Adipocytes, especially in those with metabolically-unhealthy obesity, secrete inflammatory cytokines, which may cause or exacerbate endothelial dysfunction and insulin resistance [37]. Waist circumference confers cardiovascular and metabolic disease risks above and beyond body fat or BMI, even in children with obesity [38, 39]. The implication of waist circumference on the health of individuals with CHD is suggested by findings in one of the few studies of cardiometabolic health in children with CHD by Zaqout et al. [40]. These investigators reported higher waist circumference, in addition to fasting insulin, and insulin resistance-homeostasis model in children with CHD compared to healthy controls, despite similar levels of objectively measured physical activity [40]. In one of the few studies specifically investigating waist circumference in children with CHD, Haapala et al. [26] measured children with chronic disease (including CHD) and found that waist circumference explained some of the relationship between arterial stiffness and decreased exercise capacity which was unaffected by sport participation (a surrogate measure of physical activity). These reports suggest that waist circumference may be a contributor, underpinning decreased fitness and elevated cardiovascular disease risk in pediatric clinical populations [26, 40]. Our study extends the prior work of Haapala et al. [41] by demonstrating that children with CHD have elevated waist circumference despite no difference in level of physical activity compared to healthy controls.

Physical activity in children with CHD

Our findings indicate that physical activity scores were not significantly different between children with CHD and healthy controls. Consistent with our observations, a recent study by Stone et al. [42] in a younger population (3–5 years) with CHD reported similar levels of physical activity to healthy controls. The study by Zaqout et al. [40] showed greater self-reported physical activity levels in children with CHD compared to healthy controls but no difference in accelerometer-measured physical activity.

Our findings do; however, contrast those of Ray et al. [13] who reported that physical activity in children with CHD 10–14 years was lower than levels reported in age-matched healthy children. Discrepant findings may reflect the known error susceptibility of self-reporting physical activity, or differences between self-reported and objectively measured physical activity as in the study by Zaqout et al. [40]. Such discrepancies may also reflect recent changes to exercise prescription for children with CHD [12]. Indeed, previous recommendations that children with CHD should not participate in sport or leisure time physical activity to the same degree as healthy children has been replaced by encouraging 60 min of moderate-to-vigorous physical activity per day for optimal development [43].

Effect of physical activity on waist circumference

The relationships between physical activity, adiposity, and waist circumference are well established in healthy adults, adolescents, and children [33, 44]. A prospective study in healthy Canadian children and adolescents by Carson et al. [45] found that waist circumference at baseline and at the end of the 2-year study was lower in the highest vigorous physical activity quartile after adjustment for age, sex, diet, accelerometer wear time, and time spent in other intensities of physical activity. Ekelund et al. [32] found a mean waist circumference difference of 2 cm between healthy children in the top and healthy children in the bottom tertiles of time spent in moderate-to-vigorous physical activity. We found a similar relationship but at a much greater magnitude with a 26 cm difference between the top and bottom quartile of physical activity with CHD and control groups combined. The difference between studies is likely due in part to the large difference in sample size as the study by Ekelund et al. [32] included data from over 20,000 children. In the current study, CHD was overrepresented in the lowest physical activity quartile potentially contributing to the large spread in the waist circumference values between tertiles; although, the difference in the distribution of CHD and controls over quartiles was not significant (data not shown). Our findings also indicate that the relationship between physical activity and waist circumference is stronger in controls than in CHD. We also identified a 3.9 cm difference in waist circumference between CHD and controls independent of physical activity. Taken together, these findings suggest that while physical activity influences waist circumference and contributes to the identified group difference in waist circumference, there are other factors involved. We suspect that waist circumference may be intrinsically linked (whether causally or associatively) with CHD and may contribute to population specific health disparities independent of level of physical activity.

A mechanistic link between waist circumference and cardiovascular disease risk in CHD

One way in which waist circumference may be uniquely related to CHD is through early exposure to elevated psychological stress leading to inflammation. CHD is associated with signs of stress in infants and subjective feelings of stress in older children [46, 47]. Exposure to early life stress can permanently alter metabolic and adipose properties resulting in higher cortisol, and abdominal fat deposition in later life as demonstrated with rodent models [48]. Chronic social and cognitive stress is associated with elevated inflammatory markers such as interleukins and C-reactive protein. Mediated by the hypothalamo-pituitary-adrenal axis, this inflammatory processes is intimately linked with overweight, obesity, and abdominal fat and its sequelae of comorbidities including risk factors for cardiovascular disease and coronary artery disease [49]. Inflammation may play an early role in altered vascular dynamics as inflammatory cytokines are elevated in young children with CHD [50]. For example, in young children with CHD (up to 3 years), circulating inflammatory cytokines (macrophage migration inhibitory factor chemokine, T-cells, interleukin-17 and Th2 immune response mediator) are positively correlated with the severity of the disease, and with pulmonary vascular resistance and congestion [50]. Physical activity is known to decrease adiposity and BMI, and markers of stress and chronic inflammation, and to mitigate the association between stress and adiposity in otherwise healthy children [51–54]. Physical activity has similar health benefits in children with CHD [16, 40, 55–57]; thus early stress experienced by children with CHD may underlie findings of elevated waist circumference, and weaker associations between physical activity and waist circumference. The theory is compelling that there exists a cascade whereby early physical and psychological stress leads to elevated inflammation and cortisol, which drives elevated abdominal fat accrual, further contributing to inflammation and vascular alteration, which cannot be fully offset by physical activity, and ultimately leading to increased cardiovascular disease risk.

Limitations

This study was a cross-sectional design with data from a small cohort of children and as such was unable to look at change over time or infer causation of elevated waist circumference in children with CHD. Our novel analysis was performed on our CHAMPS cohort and thus our sample size was driven based on participants with the needed metrics for the primary purposes of exploring possible waist circumference differences in the CHD study group. Given our observation of differences in waist circumference in our relatively small study, we are encouraged to explore further these observations in a larger and more thoroughly characterized CHD patient group. Dietary data was not available on participants. Elevated caloric intake or suboptimal food choices may be present in the CHD cohort due to a history of encouraging weight gain and thus may influence abdominal fat accrual. Furthermore, dietary supplements and patterns leading to hyperlipidemia can accelerate or mitigate the development of atherosclerosis and cardiovascular disease [58]. Waist circumference is a surrogate measure of abdominal fat, and physical activity was self-reported. Future studies should attempt to use objective measures for each. Although early stress experiences are likely in this cohort, measures of stress and their relationship to inflammation were not measured in this study, but should be pursued in the future. Finally, this was a heterogeneous group of children regarding the type and severity of CHD, and due to the small sample size, we could not control for lesion differences. Findings may not be generalizable to all CHD presentations.

Clinical relevance: future cardiovascular disease risk for children with CHD

Abdominal fat accrual has strong associations with arterial stiffness and cardiovascular disease risk, and predicts left ventricular mass and diastolic function independent of BMI in healthy children and adults [21, 59–61]. Increased arterial stiffness [16] and abnormal cardiac function are common in children with various CHD lesions [62], and these disparities compared to healthy controls may worsen with age [63]. As such, children with CHD appear to be at an elevated risk of early-onset chronic cardiovascular diseases like hypertension and coronary artery disease, and metabolic diseases like type 2 diabetes [1]. With improvements in the long-term prognosis of children with CHD, the prevalence of these diseases in adult survivors is increasing [1, 40]. This increased life expectancy justifies the urgency of identifying the mechanisms behind disease disparities and factors to which these risks are amenable, such as lifestyle (e.g., physical activity) and body composition. Abdominal adiposity (potentially driven by stress exposure) may be a key factor in disease development and progression in this population, thus studies exploring the role of waist circumference in the etiology of cardiovascular disease in the CHD population is clearly warranted.

Conclusions

The results from the current study highlight the complexity of the relationship between waist circumference and physical activity. The potential role of waist circumference on the discrepancy in exercise capacity and tolerance, and arterial stiffness in this population needs further exploration, but it is supported by findings in healthy children in which the relationship between fitness and arterial stiffness is attenuated after adjustment for adiposity including waist circumference [7]. Indeed, physical activity and fitness may not ensure cardiovascular health if adiposity levels, particularly abdominal adiposity levels, are elevated. Further studies on waist circumference (and abdominal adiposity) in CHD with the ability to clarify this connection are needed in an attempt to aid in the prevention, detection, and appropriate treatment of cardiovascular disease in the CHD population [2].

Acknowledgements

We gratefully acknowledge the participants and families of CHAMPS (Children’s Healthy-Heart Activity Monitoring Program in Saskatchewan), CHAMPS patient/family advocates Lynne Telfer RN and Juanita Praksis, RN, and CHAMPS collaborators Marie Penner, RN and Angela Wiens, RN.

Abbreviations

BMI

Body mass index

CHAMPS

Children’s Healthy-Heart Activity Monitoring Program in Saskatchewan

CHD

Congenital heart disease

DXA

Dual-energy x-ray absorptiometry

Authors’ contributions

M.C.E, C.R.T, K.D.W, C. P, A.K, and S. P developed the study concept and design. M.C.E, C.R.T, K.D.W A. K, and S.P. secured funding from the Jim Pattison Children’s Hospital Foundation (Grant: #416803) in Saskatoon, Saskatchewan, Canada. C.R.T, D.S.L, C.L.B, C. P, S. R, A. K, S. P, K.D.W, and M.C.E performed participant recruitment and data collection. E.B.T, N.G.B, C.R.T, D.S.L, C.L.B, and M.C.E performed data processing, statistical analyses, and/or data interpretation. E.B.T, N.G.B, C.R.T, and M.C.E drafted the article. E.B.T, N.G.B, C.R.T, D.S.L, C.L.B, C. P, S. R, A. K, S. P, T.J.B, K.D.W, and M.C.E performed critical review of the article. All authors have read and approved the manuscript.

Funding

This work was supported by the Jim Pattison Children’s Hospital Foundation (grant number 416803) in Saskatoon, Saskatchewan, Canada. The funding body was not involved in the study design, data collection, analysis and interpretation or writing of the manuscript.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

Ethics approval was obtained from the University of Saskatchewan’s Biomedical Research Ethics Board (Bio # 15–148). Written parental consent and child assent were obtained prior to testing.

Consent for publication

Not applicable.

Competing interests

None.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Giannakoulas G, Dimopoulos K, Engel R, et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445–1450. doi: 10.1016/J.AMJCARD.2009.01.353. [DOI] [PubMed] [Google Scholar]
  • 2.Tutarel O. Acquired heart conditions in adults with congenital heart disease: a growing problem. Heart. 2014;100:1317–1321. doi: 10.1136/heartjnl-2014-305575. [DOI] [PubMed] [Google Scholar]
  • 3.Madsen NL, Marino BS, Woo JG, et al. Congenital heart disease with and without cyanotic potential and the long-term risk of diabetes mellitus: a population-based follow-up study. J Am Heart Assoc. 10.1161/JAHA.115.003076. [DOI] [PMC free article] [PubMed]
  • 4.Chung ST, Hong B, Patterson L, et al. High overweight and obesity in Fontan patients: a 20-year history. Pediatr Cardiol. 2016;37:192–200. doi: 10.1007/s00246-015-1265-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Magnussen CG, Smith KJ, Juonala M. When to prevent cardiovascular disease? As early as possible: lessons from prospective cohorts beginning in childhood. Curr Opin Cardiol. 2013;28:561–568. doi: 10.1097/HCO.0b013e32836428f4. [DOI] [PubMed] [Google Scholar]
  • 6.Palve KS, Pahkala K, Magnussen CG, et al. Association of Physical Activity in childhood and early adulthood with carotid artery elasticity 21 years later: the cardiovascular risk in young Finns study. J Am Heart Assoc. 2014;3:e000594. doi: 10.1161/JAHA.113.000594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sakuragi S, Abhayaratna K, Gravenmaker KJ, et al. Influence of adiposity and physical activity on arterial stiffness in healthy children the lifestyle of our kids study. Hypertension. 2009;53:611–616. doi: 10.1161/HYPERTENSIONAHA.108.123364. [DOI] [PubMed] [Google Scholar]
  • 8.Gralla MH, McDonald SM, Breneman C, et al. Associations of objectively measured vigorous physical activity with body composition, cardiorespiratory fitness, and Cardiometabolic health in youth: a review. Am J Lifestyle Med. 2016. 10.1177/1559827615624417. [DOI] [PMC free article] [PubMed]
  • 9.Andersen LB, Harro M, Sardinha LB, et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (the European youth heart study) Lancet. 2006;368:299–304. doi: 10.1016/S0140-6736(06)69075-2. [DOI] [PubMed] [Google Scholar]
  • 10.Sherar LB, Eisenmann JC, Chilibeck PD, et al. Relationship between trajectories of trunk fat mass development in adolescence and cardiometabolic risk in young adulthood. Obesity (Silver Spring) 2011;19:1699–1706. doi: 10.1038/oby.2010.340. [DOI] [PubMed] [Google Scholar]
  • 11.Moola F, Faulkner GEJ, Kirsh JA, Kilburn J. Physical activity and sport participation in youth with congenital heart disease: perceptions of children and parents. Adapt Phys Act Q. 2008;25:49–70. doi: 10.1123/apaq.25.1.49. [DOI] [PubMed] [Google Scholar]
  • 12.Moola F, McCrindle BW, Longmuir PE. Physical activity participation in youth with surgically corrected congenital heart disease: devising guidelines so Johnny can participate. Paediatr Child Health. 2009;14:167–170. doi: 10.1093/pch/14.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ray TD, Green A, Henry K. Physical activity and obesity in children with congenital cardiac disease. Cardiol Young. 2011;21:603–607. doi: 10.1017/S1047951111000540. [DOI] [PubMed] [Google Scholar]
  • 14.Pasquali SK, Marino BS, Pudusseri A, et al. Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure. Am Heart J. 2009;158:473–479. doi: 10.1016/j.ahj.2009.06.019. [DOI] [PubMed] [Google Scholar]
  • 15.Norozi K, Wessel A, Alpers V, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006. 10.1016/j.amjcard.2005.10.065. [DOI] [PubMed]
  • 16.Boyes NG, Stickland MK, Fusnik S, et al. Physical activity modulates arterial stiffness in children with congenital heart disease: a CHAMPS cohort study*. Congenit Heart Dis. 2018. 10.1111/chd.12614. [DOI] [PubMed]
  • 17.Jung U, Choi M-S. Obesity and its metabolic complications: the role of Adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184–6223. doi: 10.3390/ijms15046184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Aballay LR, Eynard AR, Díaz Mdel P, et al. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev. 2013;71:168–179. doi: 10.1111/j.1753-4887.2012.00533.x. [DOI] [PubMed] [Google Scholar]
  • 19.Ong KK, Dunger DB. Birth weight, infant growth and insulin resistance. Eur J Endocrinol. 2004;151(Suppl):U131–U139. doi: 10.1530/eje.0.151u131. [DOI] [PubMed] [Google Scholar]
  • 20.Gardner DSL, Hosking J, Metcalf BS, et al. Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36) Pediatrics. 2009;123:e67–e73. doi: 10.1542/peds.2008-1292. [DOI] [PubMed] [Google Scholar]
  • 21.Pandit D, Khadilkar A, Chiplonkar S, et al. Arterial stiffness in obese children: role of adiposity and physical activity. Indian J Endocrinol Metab. 2014;18:70–76. doi: 10.4103/2230-8210.126565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kramer HH, Trampisch HJ, Rammos S, Giese A. Birth weight of children with congenital heart disease. Eur J Pediatr. 1990;149:752–757. doi: 10.1007/BF01957272. [DOI] [PubMed] [Google Scholar]
  • 23.Schuurmans FM, Pulles-Heintzberger CF, Gerver WJ, et al. Long-term growth of children with congenital heart disease: a retrospective study. Acta Paediatr. 2007;87:1250–1255. doi: 10.1111/j.1651-2227.1998.tb00947.x. [DOI] [PubMed] [Google Scholar]
  • 24.Voss C, Duncombe SL, Dean PH, et al. Physical activity and sedentary behavior in children with congenital heart disease. J Am Heart Assoc. 2017;6. 10.1161/JAHA.116.004665. [DOI] [PMC free article] [PubMed]
  • 25.Currie KD, Martin AA, Millar PJ, et al. Vascular and autonomic function in preschool-aged children with congenital heart disease. Congenit Heart Dis. 2012;7:289–297. doi: 10.1111/j.1747-0803.2012.00664.x. [DOI] [PubMed] [Google Scholar]
  • 26.Haapala EA, Lankhorst K, De Groot J, et al. The associations of cardiorespiratory fitness, adiposity and sports participation with arterial stiffness in youth with chronic diseases or physical disabilities. Eur J Prev Cardiol. 2017;24:1102–1111. doi: 10.1177/2047487317702792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Fowles J, Humber K, Lane K, et al. Canadian Society for Exercise Physiology - physical activity training for health (CSEP-PATH) Ottawa: Canadian Society for Exercise Physiology; 2013. [Google Scholar]
  • 28.Kowalski KC, Crocker PRE, Faulkner RA. Validation of the physical activity questionnaire for older children. Pediatr Exerc Sci. 1997;9:174–186. doi: 10.1123/pes.9.2.174. [DOI] [Google Scholar]
  • 29.Copeland JL, Kowalski KC, Donen RM, Tremblay MS. Convergent validity of the physical activity questionnaire for adults: the new member of the PAQ family. J Phys Act Health. 2005;2:216–229. doi: 10.1123/jpah.2.2.216. [DOI] [Google Scholar]
  • 30.Kowalski KC, Crocker PRE, Kowalski NP. Convergent validity of the physical activity questionnaire for adolescents. Pediatr Exerc Sci. 1997;9:342–352. doi: 10.1123/pes.9.4.342. [DOI] [Google Scholar]
  • 31.Dulloo A, Jacquet J, Seydoux J, Montani J-P. The thrifty “catch-up fat” phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome weight dynamics and risks for diseases. Int J Obes. 2006;30:23–35. doi: 10.1038/sj.ijo.0803516. [DOI] [PubMed] [Google Scholar]
  • 32.Ekelund U, Luan J, Sherar LB, et al. Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents. JAMA J Am Med Assoc. 2012;307:704–712. doi: 10.1001/jama.2012.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bowen L, Taylor AE, Sullivan R, et al. Associations between diet, physical activity and body fat distribution: a cross sectional study in an Indian population. BMC Public Health. 2015;15:281. doi: 10.1186/s12889-015-1550-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Freedman DS, Wang J, Maynard LM, et al. Relation of BMI to fat and fat-free mass among children and adolescents. Int J Obes. 2005. 10.1038/sj.ijo.0802735. [DOI] [PubMed]
  • 35.Ong KK. Size at birth, postnatal growth and risk of obesity. Horm Res. 2006;65:65–69. doi: 10.1159/000091508. [DOI] [PubMed] [Google Scholar]
  • 36.Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284–294. doi: 10.1111/j.2047-6310.2012.Y00064.x. [DOI] [PubMed] [Google Scholar]
  • 37.Perticone F, Ceravolo R, Candigliota M, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001. 10.2337/diabetes.50.1.159. [DOI] [PubMed]
  • 38.Rizzo NS, Ruiz JR, Oja L, et al. Associations between physical activity, body fat, and insulin resistance in adolescents. The European youth heart study. Ann Nutr Metab. 2007;51:341. doi: 10.1016/S0084-3741(08)79230-8. [DOI] [PubMed] [Google Scholar]
  • 39.Khokhar A, Chin V, Perez-Colon S, et al. Differences between metabolically healthy vs unhealthy obese children and adolescents. J Natl Med Assoc. 2017. 10.1016/j.jnma.2017.02.008. [DOI] [PubMed]
  • 40.Zaqout M, Vandekerckhove K, Michels N, et al. Physical fitness and metabolic syndrome in children with repaired congenital heart disease compared with healthy children. J Pediatr. 2017;191:125–132. doi: 10.1016/j.jpeds.2017.08.058. [DOI] [PubMed] [Google Scholar]
  • 41.Veijalainen A, Tompuri T, Haapala EA, et al. Associations of cardiorespiratory fitness, physical activity, and adiposity with arterial stiffness in children. Scand J Med Sci Sports. 2016;26:943–950. doi: 10.1111/sms.12523. [DOI] [PubMed] [Google Scholar]
  • 42.Stone N, Obeid J, Dillenburg R, et al. Objectively measured physical activity levels of young children with congenital heart disease. Cardiol Young. 2015;25:520–525. doi: 10.1017/S1047951114000298. [DOI] [PubMed] [Google Scholar]
  • 43.Takken T, Giardini A, Reybrouck T, et al. Recommendations for physical activity, recreation sport, and exercise training in paediatric patients with congenital heart disease: a report from the exercise, basic &amp; translational research section of the European Association of Cardiovascular Preve. Eur J Prev Cardiol. 2012;19:1034–1065. doi: 10.1177/1741826711420000. [DOI] [PubMed] [Google Scholar]
  • 44.Sherar L, Cumming S. Physical activity, physical fitness, and health. In: Armstrong N, Van Mechelen W, editors. Children’s sport and exercise medicine, Third. Oxford: Oxford University Press; 2017. pp. 225–238. [Google Scholar]
  • 45.Carson V, Rinaldi RL, Torrance B, et al. Vigorous physical activity and longitudinal associations with cardiometabolic risk factors in youth. Int J Obes. 2014;38:16–21. doi: 10.1038/ijo.2013.135. [DOI] [PubMed] [Google Scholar]
  • 46.Torowicz D, Irving SY, Hanlon AL, et al. Infant temperament and parental stress in 3-month-old infants after surgery for complex congenital heart disease. J Dev Behav Pediatr. 2010;31:202–208. doi: 10.1097/DBP.0b013e3181d3deaa. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Apers S, Rassart J, Luyckx K, et al. Bringing Antonovsky’s salutogenic theory to life: a qualitative inquiry into the experiences of young people with congenital heart disease. Int J Qual Stud Health Well-being. 2016;11:29346. doi: 10.3402/qhw.v11.29346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Yam KY, Naninck EFG, Abbink MR, et al. Exposure to chronic early-life stress lastingly alters the adipose tissue, the leptin system and changes the vulnerability to western-style diet later in life in mice. Psychoneuroendocrinology. 2017;77:186–195. doi: 10.1016/J.PSYNEUEN.2016.12.012. [DOI] [PubMed] [Google Scholar]
  • 49.Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404. doi: 10.1152/physrev.00033.2011. [DOI] [PubMed] [Google Scholar]
  • 50.Zorzanelli L, Maeda N, Clavé M, et al. Relation of cytokine profile to clinical and hemodynamic features in young patients with congenital heart disease and pulmonary hypertension. Am J Cardiol. 2017;119:119–125. doi: 10.1016/J.AMJCARD.2016.09.020. [DOI] [PubMed] [Google Scholar]
  • 51.Puterman E, Prather AA, Epel ES, et al. Exercise mitigates cumulative associations between stress and BMI in girls age 10 to 19. Health Psychol. 2016;35:191–194. doi: 10.1037/hea0000258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Thompson D, Karpe F, Lafontan M, Frayn K. Physical activity and exercise in the regulation of human adipose tissue physiology. Physiol Rev. 2012;92:157–191. doi: 10.1152/physrev.00012.2011. [DOI] [PubMed] [Google Scholar]
  • 53.Tinius RA, Cahill AG, Cade WT. Low-intensity physical activity is associated with lower maternal systemic inflammation during late pregnancy. J Obes Weight Loss Ther. 2017:7. 10.4172/2165-7904.1000343. [DOI] [PMC free article] [PubMed]
  • 54.Després J-P. Abdominal obesity and cardiovascular disease: is inflammation the missing link? Can J Cardiol. 2012;28:642–652. doi: 10.1016/j.cjca.2012.06.004. [DOI] [PubMed] [Google Scholar]
  • 55.Arvidsson D, Slinde F, Hulthén L, et al. Physical activity, sports participation and aerobic fitness in children who have undergone surgery for congenital heart defects. Acta Paediatr 2009;98:1475–82. 10.1111/j.1651-2227.2009.01369.x. [DOI] [PubMed]
  • 56.Dulfer K, Helbing WA, Duppen N, Utens EMWJ. Associations between exercise capacity, physical activity, and psychosocial functioning in children with congenital heart disease: a systematic review. Eur J Prev Cardiol. 2014;21:1200–1215. doi: 10.1177/2047487313494030. [DOI] [PubMed] [Google Scholar]
  • 57.Harris KC, Voss C, Rankin K, et al. Modifiable cardiovascular risk factors in adolescents and adults with congenital heart disease. Congenit Heart Dis. 2018;13:563–570. doi: 10.1111/chd.12612. [DOI] [PubMed] [Google Scholar]
  • 58.Scicchitano P, Cameli M, Maiello M, et al. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32. doi: 10.1016/j.jff.2013.12.006. [DOI] [Google Scholar]
  • 59.Corrigan FE, Kelli HM, Dhindsa DS, et al. Changes in truncal obesity and fat distribution predict arterial health. J Clin Lipidol. 2017;11:1354–1360.e3. doi: 10.1016/j.jacl.2017.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Dencker M, Wollmer P, Karlsson MK, et al. Body fat, abdominal fat and body fat distribution related to cardiovascular risk factors in prepubertal children. Acta Paediatr. 2012;101:852–857. doi: 10.1111/j.1651-2227.2012.02681.x. [DOI] [PubMed] [Google Scholar]
  • 61.Mehta SK, Richards N, Lorber R, Rosenthal GL. Abdominal obesity, waist circumference, body mass index, and echocardiographic measures in children and adolescents. Congenit Heart Dis. 2009;4:338–347. doi: 10.1111/j.1747-0803.2009.00330.x. [DOI] [PubMed] [Google Scholar]
  • 62.Mivelaz Y, Leung MT, Zadorsky MT, et al. Noninvasive assessment of vascular function in postoperative cardiovascular disease (Coarctation of the aorta, tetralogy of Fallot, and transposition of the great arteries) Am J Cardiol. 2016;118:597–602. doi: 10.1016/j.amjcard.2016.05.055. [DOI] [PubMed] [Google Scholar]
  • 63.Voges I, Jerosch-Herold M, Hedderich J, et al. Implications of early aortic stiffening in patients with transposition of the great arteries after arterial switch operation. Circ Cardiovasc Imaging. 2013;6:245–253. doi: 10.1161/CIRCIMAGING.112.000131. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Articles from BMC Cardiovascular Disorders are provided here courtesy of BMC

RESOURCES